3rd LNP Immunogenicity & Toxicity Summit is held on December 9-11 in Boston, MA.With the applications of LNPs rapidly expanding beyond vaccines, as well as beyond the liver, it is of utmost importance to predict and minimize adverse reactions to guarantee patient safety in the clinic, especially following a clinical hold on Verve Therapeutics' gene therapy earlier this year, due to safety concerns surrounding the LNP delivery system.Returning in December, the 3rd LNP Immunogenicity and Toxicity Summit will return as your unique forum uniting industry experts striving to measure, predict and monitor non-clinical and clinical safety risk for lipid nanoparticles to ensure regulatory compliance for vaccines, gene and cell therapies. 

  [Read on lnp-immunogenicity-](https://lnp-immunogenicity-toxicity-summit.com/take-part/register/?utm_source=external&utm_medium=event-listing&utm_campaign=event-listing&utm_content=media-partner/evvnt/paid/ev-47493)

The 3rd Liquid Biopsy Surveillance Summit  is held on 21-22 November 2024 in Boston, MA.Liquid biopsies are revolutionizing clinical trials, emerging as a game-changing diagnostic tool for monitoring molecular residual disease and detecting disease resistance. This breakthrough enables precise patient stratification, ensuring they receive the most effective and safe treatments. In 2024, a wave of collaborations has surged, propelling the use of liquid biopsies for MRD testing to new heights. The FDA's recognition of MRD as an endpoint in multiple myeloma marks a monumental leap forward for the field, heralding a new era in patient care and therapeutic development.The 3rd Liquid Biopsy Surveillance Summit returns as the leading East Coast forum solely dedicated to MRD detection in clinical trials to improve stage response monitoring to get patients earlier access to precision treatments. 

[Read on liquid-biopsy-surveillance-summit.com](https://liquid-biopsy-surveillance-summit.com/take-part/register/)

The Women's Health Innovation Summit convenes stakeholders and key opinion leaders to foster connections, share cutting-edge knowledge, and cultivate market expertise. This summit, taking place from September 23rd to 25th, 2024, aims to elevate women's health by uniting the ecosystem for impactful collaborations. The agenda is designed to facilitate partner meetings and showcase innovative startups in the field. Women's health is now recognized as a significant business opportunity, and the WHIS experience emphasizes community building and growth facilitation. Explore WHIS to discover how it advances the dialogue and progress in women's health through collaboration and entrepreneurship. 

[Read on kisacoresearch.com](https://kisacoresearch.com/events/womens-health-innovation-summit-2023/register)

3rd Digital Biomarkers & Clinical Measures in Neurology Summit is sheduled on 27-29 August 2024 in Boston, MA.From the latest validated research on implementing speech, cognition, and motor tracking measures into clinical development, to navigating the regulatory and commercial landscape, the 3rd Digital Biomarkers and Clinical Measures for Neurology Summit is the ultimate platform to take your digital strategy to the next level. 

 [Read on digital-biomarkers-neurology](https://digital-biomarkers-neurology.com/take-part/register/)

The 2nd ADC Toxicity Summit, scheduled from July 23rd to July 25th, 2024, presents a crucial opportunity to address the persistent challenge of toxicities hindering the progression of antibody-drug conjugates (ADCs) to clinical use. With an increasing number of companies entering the ADC arena and heightened competition, understanding translational challenges and off-target toxicities becomes paramount. This summit brings together over 80 colleagues from leading pharmaceutical companies like Pfizer, Merck, ImmunoGen, and others to discuss shared challenges in ADC toxicities, from in vitro to clinical stages. Experts will unveil novel toxicity data, discuss optimal in vivo models, explore biomarker utilization, and introduce innovative strategies to enhance ADC therapeutic index. This event aims to unite the foremost minds in ADC toxicology to offer actionable insights for predicting and mitigating toxicities, driving ADC development forward to address unmet medical needs effectively.

 [Read on adc-toxicity.com](https://adc-toxicity.com/take-part/register/)

The 5th STING & TLR-Targeting Therapies Summit emerges as a pivotal event in the realm of innate immunotherapy, scheduled from June 19th to 20th, 2024. Recognizing the innate immune system's potential in addressing unmet needs across various diseases, from challenging cancers to infectious and inflammatory conditions, this summit promises to dissect the lessons learned from the past year's developments. Amidst a landscape of emerging modalities and clinical setbacks, attendees will navigate through industry updates, patient population selection strategies, and the delicate balance between safety and efficacy. From early discovery to clinical trial rationale, the summit spans across the innate immune pathway, offering actionable insights to unlock its therapeutic potential and address critical unmet needs.

 [Read on sting-tlr-targeting-therapies.com](https://sting-tlr-targeting-therapies.com/take-part/register/)

Pharma's role within the healthcare system is under pressure due to increased demand, regulatory changes, and a growing access gap. The Reuters Events: Pharma 2024 conference, taking place in Barcelona from April 16 to April 18, 2024, brings together over 1,200 pharma professionals from various functions to collaborate on shaping the future of the industry. Together, they aim to align internal efforts, enhance value propositions, and solidify pharma's position in healthcare. The event focuses on becoming a trusted source for scientific information, leveraging digital capabilities for patient outcomes, adapting to evolving legislation, and harnessing data to meet patient needs. Tickets are available at different pricing tiers, catering to various participant categories.

 [Read on reutersevents.com](https://reutersevents.com/#about)

The rapidly evolving landscape of DDR inhibitor development sees commitment from AstraZeneca, Merck, Roche, Gilead, Artios, and IDEAYA in delivering effective cancer treatments. The 7th Annual DDR Inhibitors Summit in Boston, scheduled from 30th January 2024 at 8:30 am to 1st February 2024 at 5:00 pm, addresses the pressing need for oncology therapies. This year's conference, revamped to enhance participant experience, includes a pre-conference biomarkers focus day followed by tracks covering next-gen target discovery and clinical updates. With 150 peers in attendance, this industry-led event offers unparalleled insights into oncology innovation, synthetic lethality, and clinical development challenges.

Read on ddr-inhibitors-summit.com

The 3rd mRNA-Based Therapeutics Summit Europe, Europe's foremost gathering of mRNA experts, returns to Berlin from January 23rd at 9:00 am to January 25th at 5:00 pm. Featuring exclusive data from industry trailblazers like MHRA, EMA, BioNTech, CureVac, Ziphius Vaccines, and Moderna, the event convenes 250+ specialists across 3 days. Attendees delve into revolutionary discoveries, pre-clinical and clinical insights in mRNA therapeutic and vaccine development, fostering accelerated R&D and pipeline expansions in this groundbreaking field.

 [Read on mrnabased-therapeutics](https://mrnabased-therapeutics-europe.com/)

Access the global biopharma community all under one roof at BIO-Europe­­®. After being delivered virtually for two years, the event returned face-to-face in 2022 breaking all records—becoming the biopharma reunion of the year. In 2023, BIO-Europe will continue to raise the bar with another record-breaking year.  The 29th annual BIO-Europe will take place November 6-8, 2023 in Munich, Germany, and it will convene over 5,000 life science professionals representing more than 2,220 companies from over 60 countries. Attendees will take part in 27,000 one-to-one meetings over the course of the event.

Read on go.evvnt.com

Stay ahead of the curve in lipid nanoparticle (LNP) development at the 2nd Lipid Nanoparticle Development Europe Summit. Join 100+ senior leaders from the biopharma industry and gain exclusive insights into maximizing the potential of this non-viral delivery system. Collaborate with industry pioneers, including CPI, Pfizer, and GSK, to optimize end-to-end characterization, formulation, and scale-up processes. Explore the therapeutic promise of LNPs in delivering complex payloads, with a focus on clinical utility, scalability, and product quality. Don't miss this opportunity in October to harness the power of LNPs as a cutting-edge delivery vehicle.

Read on go.evvnt.com

The momentum of innate immune cell R and D is growing exponentially to harness innate immune responses and promote gold-standard allogeneic therapies. Now is the time to gather this fledgling community and build further collaboration at the centre of innovation: in Europe.

The Innate Killer Summit Europe gathers 80+ key European Gamma Delta T, NK, iNKT, neutrophil, and macrophage developers in October to chase the holy grail of efficacious, off-the-shelf, solid tumour immunotherapies through effective and scalable engineering, engager and combination strategies that promote safe, potent and persistent innate immune therapies following application.

Seize your chance to network with innate immune trailblazers from the likes of Sanofi, Takeda, Lift Biosciences, Mink Therapeutics, Affimed, Carisma Therapeutics, Arovella Therapeutics and receive 3-days of some of the best scientific and data driven case studies that will help propel your innate immune therapy into the clinic and beyond.

Read on go.evvnt.com

The course will take place in Jerusalem, at the historic Mishkenot Sha'ananim complex in the picturesque Yemin Moshe neighborhood of Jerusalem, which is the ideal venue for this interactive postgraduate teaching program.

Jerusalem is an exceptional location for the course. Sacred to the three major Monotheistic faiths, and with a history going back 5000 years, Jerusalem has something to offer everyone, from the colorful narrow alleyways of the bazaars of the old city, to the youthful and vibrant road side cafes and restaurants of modern Jerusalem.  The diversity of this beautiful city adds to the unique experience for all participants of this course.

We look forward to welcoming you to Jerusalem in October 2023.

Read on go.evvnt.com

The 2nd mRNA Process Development and Manufacturing Summit returns to Boston as the most comprehensive and technical industry dedicated forum, to address key industry bottlenecks from securing quality starting materials, quality by design and automated large-scale manufacturing, to ultimately reduce costs of mRNA production whilst harmonizing with regulatory expectations. 50+ world-class industry experts including leading mRNA players from Moderna, BioNTech, CureVac, Pfizer and more will take center stage across 3 jam-packed days, with 3 deep-dive content tracks on research scale, regulatory  and clinical scale, and commercial scale covering key areas from plasmid DNA manufacturing, in vitro transcription, purification and mRNA drug product development to help accelerate your mRNA drugs into the clinic and through to market.   Join 250+ VPs, Directors and Heads of Process Development, Drug Substance, CMC, and MSAT at the world's only end-to-end meeting enabling scalable, cost-effective and commercially viable global mRNA production.

Read on go.evvnt.com

The 2nd Cell Therapy Analytical Development Summit Europe is an unmissable event for Europe's top biotech and pharma! As the cell therapy industry continues to rapidly grow and evolve, the opportunity to learn from and collaborate with leading experts in the field will ensure that potency, characterisation and multi-region access are no longer bottlenecks in the cell therapy drug development pipeline.

Read on cell-therapy-analytics-europe.com

As more ADCs receive Accelerated Approval and Fast Track Designation, expediting the transition to the clinic becomes a strategic priority for developers. This underscores the growing need of having a manufacturing processes in place to support fast acceleration. Furthermore, as ADCs progress into later stages, establishing a robust process for guarantees product quality at a commercial scale becomes a high priority.

The inaugural ADC Process Development Summit is the ultimate platform to gain a comprehensive knowledge on the distinctive process development challenges unique to ADCs. By uniting 60+ senior executives pioneering the space, this 3-day meeting will equip you with the expertise needed to establish a high-quality process that meets shortened timelines.

Through unravelling key technical insights ranging from, discussing high quality and high yielding conjugation, impurity purification, drug product lyophilization and formulation, and engaging in regulatory discussions, this meet will leave no aspect of ADC Process Development unexplored.

Read on go.evvnt.com

Innovative solutions to the greatest challenges in pharmaceutical, biologics and device development.
The 2023 Summit covers small molecules and biologics, new technologies, innovations and combination products/medical device concepts and case studies in areas such as:

• Enabling Bioperformance Prediction Through Data Analytics
• Engineering Prodrug Therapies for Infectious Disease and Cancer Therapy
• Predictive high-throughput screening of oligonucleotide lipid nanoparticle for gene silencing
• Targeted delivery of pharmacological agents in the vascular system
• The evolving paradigm of post-market safety reporting for combination products
• The Port Delivery System with Ranibizumab: A New Paradigm for Long-Acting Retinal Drug Delivery
• Current Challenges and Opportunities in Developing Combination Products Biologics Delivery and Medical Devices
• Development of high-volume wearable drug delivery systems
  Read on ddfsummit.com

BioPharm America is a unique partnering conference where the new wave of life science innovators partner to fuel the future of drug development. For the first time, this event will be held in Raleigh, North Carolina, September 13–14, 2023, a booming hub of research, innovation, manufacturing, and partnerships.  EBD Group is committed to providing a forum for the global biopharma community to come together from anywhere in the world that is why this year's event will also feature two additional days of digital partnering, September 18–19, 2023, in the week following the in-person event.

Read on go.evvnt.com

BioPharm America is a unique partnering conference where the new wave of life science innovators partner to fuel the future of drug development. For the first time, this event will be held in Raleigh, North Carolina, September 13–14, 2023, a booming hub of research, innovation, manufacturing, and partnerships.

EBD Group is committed to providing a forum for the global biopharma community to come together from anywhere in the world that is why this year's event will also feature two additional days of digital partnering, September 18–19, 2023, in the week following the in-person event.

Over the last 16 years, BioPharm America bring together executives from major pharmaceutical companies, biotechnology companies of every size and stage, investors, and academic institutions to engage and drive drug development further. The event will cater to the needs of the entire value chain with thought-provoking program discussions, innovative company presentations and a variety of networking opportunities, making this an important forum for companies to meet and do business.

This year will also feature the return of the Startup Springboard, a lively competition offering a platform for 12 selected startup companies to make a pitch and participate in a live feedback session with a jury of leading investors, pharma dealmakers, and biotech business key opinion leaders who will evaluate the pitches and select the winner.

Read on go.evvnt.com

Last year was momentous for the cell therapy field: it was the year that CAR-T therapies became CURATIVE.

This decade of success has resulted in explosive investment into the development of CAR and TCR based approaches to ensure more patients around the world can benefit from these lifesaving therapies.   The 8th CAR-TCR Summit is returning to Boston as the industry's trusted, definitive, end-to-end forum for the global network of autologous and allogeneic cell therapy drug developers. Ensure your whole team stays ahead of the curve with unmatched industry insights shared across discovery through to commercialization.  Across 3 conference days with 8 content tracks, and an additional 6 deep-dive workshops, bootcamp, focus day, diversity session, C-level think tank and more, 200+ CAR and TCR experts will lead you and over 1,000 peers in discussions that will accelerate your pipeline, bringing better drugs to patients faster.

Read on car-tcr-summit.com

The Inaugural Gene Therapy Potency Summit (August 29-31) is dedicated to providing you with tools to identify, characterize and measure potency, enabling you to take tactical insights back to your team. The content will focus on the "sweet spot" of drug development where potency is most critical - pre-clinical development through to commercialization.

This is the only industry-led event dedicated to covering all challenges associated with potency for gene therapy drug developers specifically. We will unite with 60+ analytical, bioassay, Quality Control, regulatory and CMC experts to bring together content that gives actionable insights by combining both strategic and technical content.

Read on genetherapy-potency-assay.com

Coming out of COVID19 - 2023 is expected to see increased pressures on pharma due to cost and supply chain, but also presents plenty of opportunities to innovate with the advent of new modalities, AI, automation. It is also a pivotal year with Annex 1 being enforced and an increased focus on growth and profit pressure.

PDA is holding the 2023 PDA Pharmaceutical Manufacturing and Quality Conference that will take place on 15-16 August 2023 at PARKROYAL on Beach Road, Singapore.​ The program's theme is "The Way Forward: Trends, Technologies and New Regulations Transforming Pharmaceutical Manufacturing." The focus of this year's conference will be the current and future trends, technologies and new regulatory expectations that are transforming the Pharmaceutical Manufacturing Industry. With the exciting topics and a stellar line-up of speakers, this conference is certainly not to be missed!

Read on go.evvnt.com

Coming out of COVID19 - 2023 is expected to see increased pressures on pharma due to cost and supply chain, but also presents plenty of opportunities to innovate with the advent of new modalities, AI, automation. It is also a pivotal year with Annex 1 being enforced and an increased focus on growth and profit pressure.

PDA is holding the 2023 PDA Pharmaceutical Manufacturing and Quality Conference that will take place on 15-16 August 2023 at PARKROYAL on Beach Road, Singapore. The program's theme is "The Way Forward: Trends, Technologies and New Regulations Transforming Pharmaceutical Manufacturing." The focus of this year's conference will be the current and future trends, technologies and new regulatory expectations that are transforming the Pharmaceutical Manufacturing Industry. With the exciting topics and a stellar line-up of speakers, this conference is certainly not to be missed!

Over the two-day conference, delegates can expect in-depth presentations and discussions on the most important issues facing the industry today.

Read on go.evvnt.com

With UPSIDE Foods recently receiving 'no further questions' from the FDA, the race to advance cultivated meat and seafood from petri to plate is on! As the field turns their focus to optimizing their bioprocess and refining cost-effective scale-up approaches, don't miss your opportunity to hear detailed case-studies to advance your development infrastructure and bring to market cost-effective and scalable products.

At the only business-to-business forum dedicated exclusively to accelerating cultivated meat and seafood products to market, join BlueNalu, Fork and Good, Umami Meats, the Good Food Institute, the FDA and USDA and many more industry leaders to benchmark solutions for affordable bioprocessing.

Join to discuss the most prevalent issues preventing cultivated meat and seafood products from reaching the market. With sessions dedicated specifically to refining food-grade economical media and cell-development; navigating the investors minefield; building bioprocessing infrastructure and gaining regulatory insights to streamline the approval process, the Industrializing Cultivated Meat and Seafood Summit is your one-stop-shop for achieving regulatory approval and progressing your product to shelves and tabletops across the globe.

Read on industrializingcultivatedmeats.com

The Fusion Protein Engineering and Developability Summit is the definitive event catering to drug developers with novel fusion protein pipelines - it is a conference not to be missed! With rapid development in novel fusion protein pipelines fuelling the demand for practical, effective engineering techniques to accelerate developable drugs into the clinic, you simply can't miss out on this highly anticipated event. With leading experts from Roche, Merck, Bristol Myers Squibb, Abbvie and many more, this is a unique opportunity to connect with other drug developers, share innovative ideas and strategies, and gain valuable insights on cutting edge fusion application. With 24+ speakers, 3 hands-on workshops, and 2 days of packed data-driven case studies, this is set to be the definitive event of the year and you cannot afford to miss it!

Read on go.evvnt.com

Association of Pharmaceutical Research is honoured to organize 10th World Conference on Pharmaceutical Science and Drug Manufacturing which will be held on 06th & 07th July 2023, a virtual conference. The theme of the conference is “An Integrative Holistic Approach towards Pharma Science”. Pharmaceutical industry has a significant role in helping patients to get better through their medication. It helps in discovering and developing new drugs which saves many lives. Many disruptive technologies and emerging trends is going to cause a great impact to the pharmaceutical industry. The Pharmaceutical sector has to embrace these new technologies in order to provide a better health in future and also to focus on digital health. Considering this, APR brings together all the professionals, scientists, doctors, research scholars from pharmaceutical sector to share their thoughts, research works and also to discuss the recent technologies and trends.

Read on assopharm.com/

The landscape of microbiome drug development is constantly evolving. The road to market is incredibly complex and it's vital to find the right strategic partners to bring products to patients.

Microbiome Connect: Europe is the sector's premier strategic event, enabling you to discover new innovative technologies and foster connections that will ensure your company's clinical and commercial success. Bringing together the whole microbiome therapeutics ecosystem - from investors and large pharmaceutical companies, through to the most pioneering biotechs, academic institutions and solution providers - it delivers the business-critical information you need to make strategic decisions for your organisation through in-depth case studies and expanded networking opportunities.

Read on go.evvnt.com

International Conference on Medical, Pharmaceutical and Health Sciences(ICMPH) will be held during 02nd Jul-03rd Jul 2023 at Malé, Maldives. ICMPH is being organized by Global Society for Research and Development (GSRD). The aim of the conference is to provide the platform for Students, Engineers, Researchers and Scientists to share the knowledge and ideas in the recent trends in the field of Science, Engineering & Technology. ICMPH- will provide an excellent international forum for sharing knowledge and results in  Medical, Pharmaceutical and Health Sciences. The aim of the Conference is to provide a platform to the researchers and practitioners from both academia as well as industry to meet the share cutting-edge development in the field.
Read on :gsrd.co/Conference

The 8th Microbiome Movement Drug Development Summit returns in 2023 as North America's definitive microbiome drug development event - and it's back bigger and better than ever!

The microbiome-based therapeutic market is rapidly evolving, and it's more important than ever to showcase the efficacy of microbial-based approaches beyond C. difficile. Discover how drug developers are advancing their understanding of the role of the microbiome in disease and harnessing functionally relevant microbes for live biotherapeutic approaches.

Join us, as we provide in-depth insights into the interactions between the microbiome and metabolic pathways, host-microbe relationships in novel preclinical models, and the application of microbial-based biomarkers in clinical endpoints and diagnostic settings. Our sessions also cover the mechanistic rationale behind combination therapies, new smart clinical trial data, and GMP compliant manufacturing for stable products.

Read on microbiome-summit.com

Returning for the 12th Annual Year, the HPAPI: Process Development for Highly Potent Drugs Summit will provide benchmarking, clarity, and innovations, for the safe, cost efficient and quality development of hazardous materials in pharma and biotech. 

The summit will bring together 100+ process scientists, chemists, engineers, and industrial hygienists from lab scale development to clinical and commercial manufacturing across hazardous small molecules and biologic-based therapeutics.

Read on hpapi-summit.com

SAE Media Group's 7th Annual Pre-Filled Syringes West Coast Conference will be back for 2023 in San Diego to bring together the device developers, innovative biotech, and big pharma.

This year's conference will explore the exciting advances in the combination product drug delivery space and a future outlook exploring how pharma, device developers and regulators can work together to encourage innovation.

With the injectable drug delivery industry rapidly advancing year-to-year, administration using pre-filled syringes, auto-injectors, and pen-injectors are increasingly common. Innovations in device technology, such as connected devices are leading the way in device design in addition to injectable delivery devices for novel and large volume drugs. With the need for self-administration growing, there is an enhanced demand for on-body injectors and digitalised health as well as patient centricity. We are beginning to see environmental sustainability being incorporated into aspects of device lifecycle from design to manufacturing and the use of the device. This year's conference looks to address these hot topics through case studies and industry insights.

Read on go.evvnt.com

With approvals in siRNA technology, more ASOs hurtling towards human trials in neurology, and exciting headlines in Alzheimer's and ALS, the draw of CNS targets for oligonucleotides has never been greater. Massive investments and growing pipelines in pharma and biotech alike are working to make these life-changing therapies a reality for previously undruggable targets.

Join 100+ experts and dedicated scientists at the 3rd Oligonucleotides for CNS, the definitive industry forum bringing together leaders to problem-solve, explore invention, and inspire the creation of next-generation oligonucleotide drugs for neurological disorders. Gather with specialists from Biogen, Ionis, Genentech, Eli Lilly, Servier, and Stoke, spanning disciplines of biology, chemistry, toxicology, and clinical innovation.

Read on oligonucleotides-cns.com

With investment into the Treg field at an all time high, excitement is overflowing at the prospect of these remarkable cells being game-changers in the long-term treatment of autoimmunity, inflammation and transplantation. As this enthusiasm coincides with multiple clinical readouts and several more therapies entering the clinic, it remains vital for Treg trailblazers to come together to recognize therapy efficacy, determine safety and translate the next-generation of therapies into the clinic.  

The Treg Summit returns for the 5th year to unite this dedicated community of industry and academic experts, and remains the go-to industry forum to advance both cell and non-cell based approaches to unlock the potential of Tregs to treat indications with huge unmet clinical need. 

With 3 jam-packed days of content across CAR-, TCR- and polyclonal Tregs as well as IL-2, muteins and small molecules, you won't want to miss this unrivalled opportunity to collaborate with your peers in the Treg field to explore clinical advances, discuss challenges and discover next-gen methods to take Treg therapies to the next level. 

Read on treg-directed-therapies.com

This event dives deep into blueprints to ensure the goals of R&D and commercial teams remain cardinally aligned to the broader goals of your organization. Explore how your peers ethically disseminate scientific information about products to stakeholders. Case studies and group discussions share best practices for demonstrating how products improve patient outcomes. Foster a sense of collaboration and safely connect with peers and expert presenters at this intimately-sized program. Customize your experience and address your unique concerns during dynamic Q&A after each session. Our commitment to industry perspectives keeps the program focused on what matters and dynamic session types allow you to stay engaged.

Read on q1productions.com

The 3rd REMS Innovation Summit will continue to innovate on the Risk Management space in both content and experience for everyone in attendance. Bringing back the audience favorite interactive roundtable discussions to enjoy the most engaging and complete REMS Experience! 

We will focus on REMS assessment reports, inspection readiness, the regulatory landscape including the new Guidance on Structured Product Labeling, newest tech and AI breakthroughs while focusing on reducing the patient burdens.

Read on momentumevents.com

Join us in this fantastic location and you will enjoy hearing cutting edge Scientific Content alongside our renowned Networking Receptions. You will have the chance to connect with other like-minded chemists and benefit from Questions and Answer sessions and scientific discussion after each presentation.

Whether you are looking to learn about the latest scientific updates from industry or to meet and network with other chemists – our OPR and D Conference is the place to be.

Take advantage of our global network and extensive reach.

We invite key industrial experts from around the globe to share their discoveries with you. Each speaker is hand-picked and we work hard to ensure that a wide variety of topics are covered to ensure our programme is comprehensive and relevant. You will be re-invigorated and boosted once back in the lab.

Come and improve your efficiency and learn how to be more innovative in your synthetic route design, development and optimisation.

The chemical and pharma industries are fast moving and ever changing and the efficient conversion of a chemical process into a process for manufacture on tonnage scale has always been of importance. However, in the current economic and regulatory climate, it has become increasingly vital and challenging to do so efficiently and sustainably. OPR and D focusses on all these essential aspects of the chemical industry and has a reputation for quality and excellence.

We provide a safe, comfortable environment where you can meet new partners face-to-face, network with peers, and source innovative solutions in our exhibition area.

Book with Confidence! We understand that the situation regarding Covid is changing daily and want to reassure our customers that if you find you cannot attend due to Covid, we will issue a refund or transfer your booking to a later date.

Time: 09:00 to 17:00

The past twelve months have seen an unprecedented level of excitement, investment, and progression within the gene therapy for muscular disorders field. As the industry endeavours to move gene therapy treatment through the preclinical and clinical pipeline, in context of reducing toxicity and increasing efficacy, attending the 3rd Annual Gene Therapy for Muscular Disorders Summit has never been so crucial.

This year's summit will return to Boston to reunite 100+ leading experts in biotech, pharma and academia to continue to develop strategies to deliver safer and more effective gene therapies to muscle cells.

This summit will encompass all aspects of preclinical development and highlight the obstacles in clinical trials, enabling you to address and overcome these challenges.

Read on genetherapy-muscular.com

The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to increase patient centricity, aid self-administration and deliver biologics that have large-volumes and novel formulations. This year's conference will explore the exciting advances in the combination product drug delivery space and a future outlook exploring how pharma, device developers and regulators can work together to encourage innovation.

SAE Media Group's 15th Annual Pre-Filled Syringes and Injectable Drug Devices Conference will be bigger than ever, with a pre-conference focus day exploring the advances in PFS design for enhanced drug delivery proceeded by a two-day main conference comprising of morning keynote plenaries and parallel afternoon topic streams as detailed below:

. Novel Drug Products and Large Volume Delivery

. Sustainability for Injectable Delivery Devices

. Primary Packaging Development

. Connected Drug Delivery Devices

Topics of discussion will include the latest updates in the combination product regulatory framework, insights into the evolving digital health landscape for connected delivery devices, considerations for the development of primary packaging, utilising platform technology, the delivery of novel drug formulations and large volume drug products, patient centric approaches to device design as well as sustainable approaches for device development.

This event will not only bring you key insights you need to expand and enhance your injectable device portfolio but will also give you the opportunity to network with key players throughout the industry. 

Benefits of Attending:

. Engage with industry representatives on the latest trends within the pre-filled syringe and injectable device market

. Hear about new technological advances in the delivery of large volume drugs

. Explore updates to drug device combination product design approaches considering patient preference at the forefront with case studies from big pharma representatives

. Understand the latest regulatory requirements from regulatory experts surrounding medical devices and digital health

. Delve into the considerations for material components for the development of primary packaging

. Gain insight into how big pharma are incorporating sustainable approaches into drug device design

Who should attend:

Advanz Pharma; AstraZeneca; Balda Medical GmbH and Co. KG; Bayer AG; Bayer Pharma; BD Medical; BD Medical - Pharmaceutical Systems; Becton Dickinson (BD); Boehringer Ingelheim; Boehringer Ingelheim GmbH and Co. KG; Boehringer Ingelheim Pharma GmbH and CO KG; Boehringer Ingelheim Pharma Gmbh and Co. Kg; BSI; BSI Group; Chiesi Ltd; Crux Product Design Ltd; DCA Design International; Device Development; Dr.Reddys; GlaxoSmithKline; GSK; Hoffmann-La Roche; Horizon Therapeutics GmbH; Ichnos Sciences; Janssen Pharmaceutical Companies; Johnson and Johnson; Johnson and Johnson (Janssen Pharmaceutical); Medincell; Merck Group; Midas Pharma Gmbh; Nemera; Novartis; Novo Nordisk; Novo Nordisk A/S; Owen Mumford; Pfizer; Pfizer UK; PharmaEssentia; Prescient Healthcare Group; RAUMEDIC AG; Sanofi; SCHOTT AG; SPM MEDICARE PVT LTD, INDIA; Sustainable Healthcare Coalition; Takeda; Teva; Teva Pharmaceuticals; Teva Pharmaceuticals Industries Ltd.; Teva, Combination Products; TUV Italia SRL; TUV SUD Japan Ltd.; TUV SUD Product Service GmbH; University of Liverpool; University of Southern Denmark; Zeon Europe GmbH; Zeon Specialty Materials;

SAE Media Group offer direct access to key decision makers through tailored sponsorship and exhibitor packages. 

For details, please contact Daniele Moreschi on: +44 (0)20 7827 6050 or dmoreschi@smi-online.co.uk 

For all delegate enquiries, contact Jamie Wilkinson on: +44 (0) 20 7827 6136 or jwilkinson@smi-online.co.uk 

About SAE Media Group Conferences: 

SAE Media Group Conferences connects global communities with focused networking conferences. We provide our customers with solutions through industry knowledge and collaboration that enables our attendees to return to their organisations better equipped to overcome their key business challenges. Our key events focus on Defence and Aerospace, Pharmaceutical and Medical. Each year we bring together over 5,000 senior business professionals at our conferences. http://www.smgconferences.com

SAE Media Group (SMG), a subsidiary of SAE International, reports the latest technology breakthroughs and design innovations to a global audience of nearly 1,000,000 engineers, researchers, and business managers. SMG provides critical information these professionals need to develop new and improved products and services.

URL:

Tickets: https://go.evvnt.com/1325852-0?pid=10158

Price:

General Admission: GBP 1999.00

Date and Time: 10th January 2023 at 9:00 am to 12th January 2023 at 5:00 pm

With the increasing challenges of successfully launching a new pharmaceutical product, it is essential to have the latest information on market trends, tools, and innovations to drive informed decision making relating to market introductions.

At the Launch Readiness for Medical Affairs and Communications Teams Forum, leading experts will be on hand to exchange best practices and insights that are essential to successfully launching a product in today's complex healthcare landscape.

Date and Time: 30th November 2022 at 11:00 am to 1st December 2022 at 2:45 pm

Read on medaffairslaunch.com

5th International Pharmaceutical Conference and Expo welcome you as our guest to the City of London, UK during July 22-24, 202!. The theme of the upcoming edition of i- Pharma UK  is Bridging Pharma Research with Industry.

The pharmaceutical industry has been reshaping their companies not only to the development of adopting new technology and innovation trends like AI, Blockchain, Precision Medicine, and big data, but also to increase the inclusivity of women leadership roles across the industry. Because of this, productivity and efficiency in R&D will significantly increase, and the ability to innovate will be a crucial factor to the future success of companies in the life sciences industry. 

This event is for YOU, pharma marketing, digital marketing, pharmaceutical marketing, digital pharma, forward pharma, brand marketing, product marketing, upstream marketing, downstream marketing, multichannel, omnichannel, commercialization, customer engagement, transformation, HCP, promotional mix, sales rep, fieldforcesales, forcecontent, content marketing, video content, analytics, branded website, unbranded website, product launch, virtual product launch, lead generation, Digital therapeutics, diagnostic marketing, innovation, mediapatient centricity

Read on momentumevents.com

Specialty pharmaceuticals, including some limited distribution drugs, continue to be a bigger portion of hospital outpatient pharmacy spend leaving some hospitals and health systems concerned about how to best manage this growing challenge. There is increasing interest in accredited specialty pharmacies as a solution, yet it comes with a cost and no guarantees. Many hospitals today simply don’t understand that there are other options to consider. Learn how to assess the right path for your hospital’s specialty pharmaceutical strategy in this webinar.

The pharmaceutical microbiology industry has seen many changes during the progression into the 21st century. With advances in rapid microbiological methods, revisions being made to regulations in the industry enhanced knowledge of the human microbiome, and novel testing methods this industry is ever-expanding.

Read on smi-online.co.uk